C

Crinetics Pharmaceuticals
D

CRNX

54.470
USD
-0.88
(-1.59%)
مفتوح الان
حجم التداول
5,047
الربح لكل سهم
-6
العائد الربحي
-
P/E
-12
حجم السوق
5,596,633,905
أصول ذات صلة المقالات

العنوان: Crinetics Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.